Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 39, Issue 3

Issues

Autoantibodies Associated with Rheumatic Diseases

Andrea Griesmacher / Peter Peichl
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2001.031

Abstract

The identification of circulating autoantibodies contributes to the correct diagnosis as well as to the follow-up of rheumatic diseases. Some autoantibodies are even included in diagnostic and classification criteria for these types of autoimmune diseases. There are several relatively specific screening and identification methods for the measurement of autoantibodies available. The type of assay crucially influences the diagnostic value of the parameters. In general, routine laboratories should prefer enzyme immunoassays (ELISA) using well characterized antigens, although ELISA tests tend to produce more false-positive and true weakly positive results, which reduce their positive predictive value. Therefore one should be aware that laboratory results can only be properly interpreted when there is a correlation with the clinical situation and when the limitations of the technologies used for autoantibody identification have been taken into consideration.

A diagnostic algorithm consisting of screening and identification steps should be established by each laboratory in order to create a rational, evidence-based and cost-effective basis for the diagnosis of rheumatic diseases.

About the article

Published Online: 2005-06-01

Published in Print: 2001-04-09


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 39, Issue 3, Pages 189–208, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2001.031.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Hooi-Yeen Yap, Sabrina Tee, Magdelyn Wong, Sook-Khuan Chow, Suat-Cheng Peh, and Sin-Yeang Teow
Cells, 2018, Volume 7, Number 10, Page 161
[3]
Marvin J Fritzler and Mark L Fritzler
Expert Opinion on Medical Diagnostics, 2009, Volume 3, Number 1, Page 81
[4]
O. Shovman, B. Gilburd, G. Zandman-Goddard, A. Yehiely, P. Langevitz, and Y. Shoenfeld
Autoimmunity, 2005, Volume 38, Number 1, Page 105
[5]
T. Kakinuma, B.-H. Toh, and J. W. Sentry
Modern Rheumatology, 2003, Volume 13, Number 1, Page 0015
[6]
Marjan Van Blerk, Christel Van Campenhout, Xavier Bossuyt, Jean Duchateau, René Humbel, Geneviève Servais, Jean-Paul Tomasi, Adelin Albert, Wim Coucke, and Jean-Claude Libeer
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 1
[7]
G. Aksu, N. Gulez, E. Azarsız, N. Karaca, and N. Kutukçuler
Journal of Clinical Laboratory Analysis, 2010, Volume 24, Number 4, Page 230

Comments (0)

Please log in or register to comment.
Log in